EQUITY Equity (Tables)
|
6 Months Ended |
Jun. 30, 2020 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on Cash Flow Hedge |
|
Foreign Currency Items |
|
Total |
|
(in thousands) |
|
|
|
|
| Balance at December 31, 2019 |
$ |
— |
|
|
$ |
(145,713) |
|
|
$ |
(145,713) |
|
Other comprehensive loss before reclassifications |
(36,596) |
|
|
(62,849) |
|
|
(99,445) |
|
| Amount reclassified from AOCI |
1,353 |
|
|
— |
|
|
1,353 |
|
| Net other comprehensive loss |
(35,243) |
|
|
(62,849) |
|
|
(98,092) |
|
| Balance at June 30, 2020 |
$ |
(35,243) |
|
|
$ |
(208,562) |
|
|
$ |
(243,805) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
|
Six Months Ended
June 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
(in thousands) |
|
|
|
|
|
|
| Weighted average common shares—basic |
211,693,923 |
|
|
209,998,048 |
|
|
211,371,109 |
|
|
209,456,196 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
— |
|
|
9,636,873 |
|
|
— |
|
|
9,651,155 |
|
| Convertible senior notes |
— |
|
|
342,691 |
|
|
— |
|
|
— |
|
| Weighted average common shares—diluted |
211,693,923 |
|
|
219,977,612 |
|
|
211,371,109 |
|
|
219,107,351 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
|
Six Months Ended
June 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
| Options to purchase shares of common stock |
10,197,507 |
|
|
486,849 |
|
|
10,197,507 |
|
|
486,849 |
|
| Restricted stock and deferred stock—unvested |
5,150,289 |
|
|
1,326,480 |
|
|
5,150,289 |
|
|
1,365,825 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
11,864,035 |
|
|
8,085,275 |
|
|
11,864,035 |
|
|
8,085,275 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
27,211,831 |
|
|
9,898,604 |
|
|
27,211,831 |
|
|
9,937,949 |
|
|